These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8122962)

  • 1. HIV-1 protease inhibitors: development, status, and potential role in the treatment of AIDS.
    Lang M; Roesel J
    Arch Pharm (Weinheim); 1993 Dec; 326(12):921-4. PubMed ID: 8122962
    [No Abstract]   [Full Text] [Related]  

  • 2. The HIV protease and therapies for AIDS.
    Korant BD; Rizzo CJ
    Adv Exp Med Biol; 1997; 421():279-84. PubMed ID: 9330709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constraints on the sequence diversity of the protease of human immunodeficiency virus type 1: a guide for drug design.
    Kaplan AH
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):849-53. PubMed ID: 8798968
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV-1 protease as a potential target for anti-AIDS therapy.
    Meek TD; Dreyer GB
    Ann N Y Acad Sci; 1990; 616():41-53. PubMed ID: 2078031
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting the HIV-protease in AIDS therapy: a current clinical perspective.
    Tomasselli AG; Heinrikson RL
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):189-214. PubMed ID: 10708858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS].
    Mitsuya H
    Nihon Rinsho; 1991 Sep; 49(9):2062-9. PubMed ID: 1720470
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV protease as an inhibitor target for the treatment of AIDS.
    Darke PL; Huff JR
    Adv Pharmacol; 1994; 25():399-454. PubMed ID: 8204507
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV protease: a novel chemotherapeutic target for AIDS.
    Huff JR
    J Med Chem; 1991 Aug; 34(8):2305-14. PubMed ID: 1875332
    [No Abstract]   [Full Text] [Related]  

  • 9. Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.
    Ikuta K; Suzuki S; Horikoshi H; Mukai T; Luftig RB
    Microbiol Mol Biol Rev; 2000 Dec; 64(4):725-45. PubMed ID: 11104817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV protease inhibitors (new possibilities in the treatment of HIV infection and AIDS)].
    Bálint GS
    Orv Hetil; 1998 Jun; 139(24):1471-4. PubMed ID: 9658865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV-1 protease as a therapeutic target for AIDS.
    Debouck C
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):153-64. PubMed ID: 1540403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continued therapy with HIV-1 protease inhibitors, despite previous hypersensitivity reactions, through coadministration of prednisone.
    Prins JM; Schellekens PT; Reiss P
    Scand J Infect Dis; 1998; 30(6):612-3. PubMed ID: 10225393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children.
    Rosso R; Di Biagio A; Dentone C; Bassetti M; Viscoli C; Parodi A; De Maria A
    Int J Antimicrob Agents; 2007 Feb; 29(2):228-30. PubMed ID: 17196369
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV and AIDS. Gap between biology and reality in AIDS.
    Carr A; Cooper DA
    Lancet; 1998 Dec 19-26; 352 Suppl 4():SIV16. PubMed ID: 9872163
    [No Abstract]   [Full Text] [Related]  

  • 15. [New therapeutic possibilities in AIDS].
    Heinzl S
    Med Monatsschr Pharm; 1996 May; 19(5):121. PubMed ID: 8684307
    [No Abstract]   [Full Text] [Related]  

  • 16. Protease inhibitor approved for AIDS treatment.
    AORN J; 1996 Sep; 64(3):453. PubMed ID: 8876926
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS activists seek speedy access to protease drugs...
    Gavaghan H
    Nature; 1995 Mar; 374(6517):4. PubMed ID: 7870168
    [No Abstract]   [Full Text] [Related]  

  • 18. [New ammunition in the battle against AIDS].
    Agosto M
    Sidahora; 1997; ():25-6. PubMed ID: 11364803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protease inhibitors are effective only on HIV-infected cells].
    Fortschr Med; 1996 May; 114(15):12. PubMed ID: 8767934
    [No Abstract]   [Full Text] [Related]  

  • 20. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor.
    Murphy M; Armstrong D; Sepkowitz KA; Ahkami RN; Myskowski PL
    AIDS; 1997 Feb; 11(2):261-2. PubMed ID: 9030382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.